Identification of distant metastases with positron-emission tomography-computed tomography in patients with previously untreated head and neck cancer

Laryngoscope

Volumn 118, Issue 4, 2008, Pages 671-675

  Gourin, Christine G ^a,b   Watts, Tammara L ^a   Williams, Hadyn T ^a   Patel, Vijay S ^a   Bilodeau, Paul A ^a   Coleman, Teresa A ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Distant metastases; Head and neck neoplasms; Positron emission tomography computed tomography; Pulmonary metastases; Screening; Squamous cell cancer

Indexed keywords

ADULT; ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; DISTANT METASTASIS; FEMALE; HEAD AND NECK CANCER; HUMAN; LUNG CANCER; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; THORAX RADIOGRAPHY;

CARCINOMA, SQUAMOUS CELL; CONTRAST MEDIA; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; LARYNGEAL NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOGRAPHY, THORACIC; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, SPIRAL COMPUTED;

EID: 41849135815     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MLG.0b013e3181625737     Document Type: Article

References (25)

1. Hoffman HT, Karnell LH, Funk GF, et al. The National Cancer Data Base report on cancer of the head and neck. Arch Otolaryngol Head Neck Surg 1998;124:951-962.
2. de Bree R, Deurloo EE, Snow GB, Leemans CR. Screening for distant metastases in patients with head and neck cancer. Laryngoscope 2000;397-401.
3. Glynn F, Brennan S, O'Leary G. CT staging and surveillance of the thorax in patients with newly diagnosed and recurrent squamous cell carcinoma of the head and neck: is it necessary? Eur Arch Otorhinolaryngol 2006;263:943-945.
4. Garavello W, Ciardo A, Spreafico R, Gaini RM. Risk factors for distant metastases in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2006;132:762-766.
5. Houghton DJ, Hughes ML, Garvey C, et al. Role of chest CT scanning in the management of patients presenting with head and neck cancer. Head Neck 1998;20:614-618.
6. Teknos TN, Rosenthal EL, Lee D, et al. Positron emission tomography in the evaluation of stage III and IV head and neck cancer. Head Neck 2001;23:1056-1060.
7. Brouwer J, de Bree R, Hoekstra OS, et al. Screening for distant metastases in patients with head and neck cancer: is chest computed tomography sufficient? Laryngoscope 2005;115:1813-1817.
8. Keski-Säntti HT, Markkola AT, Mäkitie AA, et al. CT of the chest and abdomen in patients with newly diagnosed head and neck squamous cell carcinoma. Head Neck 2005;27:909-915.
9. Wax MK, Myers LL, Gabalski EC, et al. Positron emission tomography in the evaluation of synchronous lung lesions in patients with untreated head and neck cancer. Arch Otolaryngol Head Neck Surg 2002;128:703-707.
10. Perlow A, Bui C, Shreve P, et al. High incidence of chest malignancy detected by FDG PET in patients suspected of recurrent squamous cell carcinoma of the upper aerodigestive tract. J Comput Assist Tomogr 2004;28:704-709.
11. Schwartz DL, Rajendran J, Yueh B, et al. Staging of head and neck squamous cell cancer with extended-field FDG-PET. Arch Otolaryngol Head Neck Surg 2003;129:1173-1178.
12. Zimmer LA, Branstetter BF, Nayak JV, Johnson JT. Current use of 18F-fluorodeoxyglucose positron emission tomography and combined positron emission tomography and computed tomography in squamous cell carcinoma of the head and neck. Laryngoscope 2005;115:2029-2034.
13. Schöder H, Yeung HWD, Gonen M, Kraus D, Larson SM. Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion. Radiology 2004;23:65-72.
14. Brouwer J, Senft A, de Bree R, et al. Screening for distant metastases in patients with head and neck cancer: is there a role for (18)FDG-PET? Oral Oncol 2006;42:275-280.
15. Swensen SJ, Jett JR, Hartman TE, et al. Lung cancer screening with CT: Mayo clinic experience. Radiology 2003;226:756-761.
16. Goerres GW, von Schulthess GK, Steinart HC. Why most PET of lung and head and neck cancer will be PET-CT. J Nuc Ned 2004;45:66S-71S.
17. Keyes JW, Chen MYM, Watson NE, et al. FDG PET evaluation of head and neck cancer: value of imaging the thorax. Head Neck 2000;22:105-110.
18. Wong RJ, Lin DT, Schöder H, et al. Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. J Clin Oncol 2002;20:4199-4208.
19. Schöder H, Yeung HWD, Gonen M, et al. Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion. Radiology 2004;231:65-72.
20. Gordin A, Daitzchman M, Doweck I, et al. Fluorodeoxyglucose-positron emission tomography/computed tomography imaging in patients with carcinoma of the larynx: diagnostic accuracy and impact on clinical management. Laryngoscope 2006;116:273-278.
21. Branstetter BF, Blodgett TM, Zimmer LA, et al. Head and neck malignancy: is PET/CT more accurate than PET or CT alone? Radiology 2005;235:580-586.
22. Goshen E, Davidson T, Yahalom R, et al. PET/CT in the evaluation of patients with squamous cell carcinoma of the head and neck. Int J Oral Maxillofac Surg 2006;35:332-336.
23. Fleming AJ Jr, Smith SP Jr, Paul CM, et al. Impact of [18F]-2-fluorodeoxyglucose-positron emission tomography/computed tomography on previously untreated head and neck cancer patients. Laryngoscope 2007;117:1173-1179.
24. Lejeune C, Al Zahouri K, Woronoff-Lemsi MC, et al. Use of a decision analysis model to assess the medicoeconomic implications of FDG PET imaging in diagnosing a solitary pulmonary nodule. Eur J Health Econ 2005;6:203-214.
25. Buscombe J, O'Rourke E. Is 18F FDG PET-CT cost effective in lung cancer? Exp Rev Anticancer Ther 2007;7:471-476.